1. Home
  2. ICLR vs FDS Comparison

ICLR vs FDS Comparison

Compare ICLR & FDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ICON plc

ICLR

ICON plc

HOLD

Current Price

$172.23

Market Cap

9.3B

Sector

Health Care

ML Signal

HOLD

Logo FactSet Research Systems Inc.

FDS

FactSet Research Systems Inc.

HOLD

Current Price

$299.91

Market Cap

9.1B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ICLR
FDS
Founded
1990
1978
Country
Ireland
United States
Employees
N/A
6258
Industry
Biotechnology: Commercial Physical & Biological Resarch
Computer Software: Programming Data Processing
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
9.3B
9.1B
IPO Year
2001
1996

Fundamental Metrics

Financial Performance
Metric
ICLR
FDS
Price
$172.23
$299.91
Analyst Decision
Buy
Hold
Analyst Count
13
11
Target Price
$178.62
$284.80
AVG Volume (30 Days)
805.3K
736.1K
Earning Date
05-12-2026
03-31-2026
Dividend Yield
N/A
1.89%
EPS Growth
N/A
11.79
EPS
N/A
11.16
Revenue
N/A
$1,435,351,000.00
Revenue This Year
N/A
$7.16
Revenue Next Year
N/A
$5.55
P/E Ratio
$12.91
$26.89
Revenue Growth
N/A
6.31
52 Week Low
$66.57
$185.00
52 Week High
$203.91
$386.52

Technical Indicators

Market Signals
Indicator
ICLR
FDS
Relative Strength Index (RSI) 57.57 64.07
Support Level $172.65 $267.36
Resistance Level $188.49 $300.77
Average True Range (ATR) 6.78 9.79
MACD 0.57 1.06
Stochastic Oscillator 73.21 84.02

Price Performance

Historical Comparison
ICLR
FDS

About ICLR ICON plc

Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.

About FDS FactSet Research Systems Inc.

FactSet provides financial data and portfolio analytics to the global investment community. The company aggregates data from third-party data suppliers, news sources, exchanges, brokerages, and contributors into its workstations. In addition, it provides essential portfolio analytics that companies use to monitor portfolios and address reporting requirements. Buy-side clients (including wealth and corporate clients) account for over 80% of FactSet's annual subscription value. In 2015, the company acquired Portware, a provider of trade execution software. In 2017, it acquired BISAM, a risk management and performance measurement provider. In 2022, it completed its purchase of CUSIP Global Services.

Share on Social Networks: